Multiple Myeloma: An Overview

Multiple-myeloma, also known as myeloma, is a form of blood cancer that affects plasma cells in the bone marrow.
Ibrutinib (Ibruxen) is used to treat blood cancer like lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenström macroglobulinemia (WM), and marginal zone lymphoma (MZL).
Multiple-myeloma, also known as myeloma, is a form of blood cancer that affects plasma cells in the bone marrow.